A novel high throughput screening assay for HCV NS3 helicase activity

M Hicham Alaoui-Ismaili1, C Gervais, S Brunette

  • 1Department of Virology, BioChem Pharma Inc., Québec, Laval, Canada.

Antiviral Research
|June 27, 2000
PubMed
Summary

A new Flashplate assay accurately measures Hepatitis C virus (HCV) NS3 helicase activity. This reproducible method is ideal for high-throughput screening of potential antiviral drugs targeting HCV.

Related Concept Videos